Justo Lorenzo Bermejo | Genetic Epidemiology | Best Researcher Award

Best Researcher Award

Justo Lorenzo Bermejo
University of Heidelberg
Justo Lorenzo Bermejo
Affiliation University of Heidelberg
Country Germany
Scopus ID 55665790900
Documents 269
Citations 8,350
h-index 50
Subject Area Genetic Epidemiology
Event Global Academic Awards
ORCID 0000-0002-6568-5333

Justo Lorenzo Bermejo of the University of Heidelberg has been acknowledged for sustained academic productivity, extensive publication activity, and measurable citation impact within international research communities.[1] The recognition reflects contributions to epidemiological methodology, genetic risk assessment, and collaborative scientific advancement in health-related disciplines.[2]

Abstract

This academic recognition article documents the scholarly profile and research achievements of Justo Lorenzo Bermejo, whose work in genetic epidemiology has contributed to scientific understanding of disease susceptibility, population genetics, and epidemiological modeling. The article summarizes publication performance, citation metrics, collaborative research activities, and professional recognition associated with the Best Researcher Award under the Global Academic Awards framework. Emphasis is placed on measurable academic impact, peer-reviewed dissemination, and interdisciplinary scientific engagement.[1][3]

Keywords

Genetic Epidemiology, Biomedical Research, Cancer Genetics, Population Studies, Scientific Citations, Research Metrics, Epidemiological Modeling, Academic Recognition, Global Academic Awards, Genomic Research

Introduction

The Best Researcher Award is intended to acknowledge scholars whose scientific work demonstrates sustained academic productivity, methodological rigor, and international research visibility. Within biomedical sciences, genetic epidemiology has become increasingly important for understanding hereditary disease patterns, environmental interactions, and translational health applications.[4]

Justo Lorenzo Bermejo has contributed to multiple research initiatives involving statistical genetics, cancer epidemiology, and genomic risk analysis. Through collaborations with international institutions and publication in peer-reviewed journals, the researcher has established a record of scholarly engagement supported by significant citation performance and interdisciplinary influence.[2][5]

Research Profile

The research profile of Justo Lorenzo Bermejo reflects extensive scholarly activity in genetic epidemiology and biomedical statistics. The documented publication output includes 269 indexed documents and an h-index of 50, indicating sustained citation influence across multiple scientific domains.[1]

  • Primary affiliation with the University of Heidelberg, Germany.
  • Research specialization in genetic epidemiology and population-based health analysis.
  • Extensive participation in collaborative biomedical research networks.
  • High citation visibility within epidemiological and genomic research literature.

Research metrics obtained through indexed academic databases indicate substantial international engagement and peer-reviewed dissemination activity.[1]

Research Contributions

The scholarly contributions of Justo Lorenzo Bermejo include analytical investigations into hereditary cancer syndromes, epidemiological risk estimation, and genomic susceptibility factors. Several studies have addressed methodological improvements in population genetics and disease prediction models.

Published research has also examined interactions between environmental exposure and inherited genetic variation, contributing to improved understanding of multifactorial disease processes. These investigations support evidence-based approaches in preventive medicine and public health policy.

  • Development of epidemiological models for genetic disease assessment.
  • Contribution to cancer genetics and hereditary risk evaluation studies.
  • Collaboration in multidisciplinary genomic and biomedical projects.
  • Publication of peer-reviewed articles with measurable citation impact.

Publications

The publication record associated with Justo Lorenzo Bermejo includes articles in epidemiology, genetics, oncology, and statistical health sciences. Representative publications include studies indexed in international databases and associated with DOI-based scholarly citation systems.[3]

  1. Research concerning hereditary cancer risk and genomic susceptibility analysis.
  2. Studies involving population-level epidemiological data interpretation.
  3. Collaborative investigations into biomedical statistical methodologies.
  4. Peer-reviewed contributions addressing translational genetic medicine.

Examples of DOI-linked scientific literature demonstrate continued engagement with evidence-based biomedical investigation and quantitative epidemiological analysis.

Research Impact

Research impact indicators associated with the academic profile include more than 8,350 citations and a substantial h-index score, reflecting broad utilization of published findings within the scientific community.[1] Citation activity demonstrates continuing relevance in fields connected to epidemiology, genomics, cancer research, and public health analytics.

The influence of the research extends beyond publication metrics through interdisciplinary collaboration, academic mentorship, and participation in international scientific discussions related to biomedical innovation and population health assessment.[5]

Award Suitability

The academic record of Justo Lorenzo Bermejo aligns with the evaluation principles commonly associated with distinguished research recognition programs. Criteria including publication productivity, scholarly citations, international collaboration, and subject-area specialization support suitability for the Best Researcher Award within the Global Academic Awards event framework.[2]

  • Consistent contribution to peer-reviewed scientific literature.
  • Recognized impact through citation-based metrics and h-index performance.
  • Demonstrated interdisciplinary and international research collaboration.
  • Specialized expertise in genetic epidemiology and biomedical analytics.

Conclusion

The Best Researcher Award article highlights the academic achievements and scientific contributions of Justo Lorenzo Bermejo within the field of genetic epidemiology. The combination of publication productivity, citation impact, collaborative engagement, and methodological research activity reflects a sustained commitment to scholarly advancement and biomedical inquiry.[1]

The documented research profile demonstrates alignment with international standards of academic excellence and supports continued recognition within global scientific and educational communities.

References

  1. Elsevier. (n.d.). Scopus author details: Justo Lorenzo Bermejo, Author ID 55665790900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55665790900
  2. Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(26)00187-8/fulltext
  3. Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease
    https://www.sciencedirect.com/science/article/pii/S0163445325002130
  4. International Journal of Epidemiology. (n.d.). Research methodologies in genetic epidemiology.
    https://doi.org/10.1093/ije/dyr140
  5. Nature Reviews Genetics. (n.d.). Environmental and genetic determinants of disease.
    https://doi.org/10.1038/nrg2817

Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. 🦠🔬📚

Publication Profile

Scopus

Orcid

🎓 Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. 🧬🔬📖

🏅 Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. 🧪🔬📚

🔬 Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance 💊, and host-pathogen interactions 🏥. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. 🌍🔍

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan 🦠💊 (Heliyon, 2025) 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025) 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🤰🦠 (Pathogens, 2025) 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases 💊🦠 (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠🧪 (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan 💊🦠 (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024) 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review 🦠📖 (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients 💉🦠 (Human Vaccines and Immunotherapeutics, 2024) 
🔟 Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives 🦠💉 (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.